TWI367753B - Composition for normalization of infradian rhythm - Google Patents

Composition for normalization of infradian rhythm

Info

Publication number
TWI367753B
TWI367753B TW093108358A TW93108358A TWI367753B TW I367753 B TWI367753 B TW I367753B TW 093108358 A TW093108358 A TW 093108358A TW 93108358 A TW93108358 A TW 93108358A TW I367753 B TWI367753 B TW I367753B
Authority
TW
Taiwan
Prior art keywords
normalization
composition
infradian rhythm
infradian
rhythm
Prior art date
Application number
TW093108358A
Other languages
English (en)
Other versions
TW200507832A (en
Inventor
Kengo Akimoto
Yoshiko Ono
Hiroshi Kawashima
Katsuya Nagai
Original Assignee
Suntory Holdings Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suntory Holdings Ltd filed Critical Suntory Holdings Ltd
Publication of TW200507832A publication Critical patent/TW200507832A/zh
Application granted granted Critical
Publication of TWI367753B publication Critical patent/TWI367753B/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Polymers & Plastics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Anesthesiology (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
TW093108358A 2003-03-27 2004-03-26 Composition for normalization of infradian rhythm TWI367753B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2003088956 2003-03-27

Publications (2)

Publication Number Publication Date
TW200507832A TW200507832A (en) 2005-03-01
TWI367753B true TWI367753B (en) 2012-07-11

Family

ID=33095131

Family Applications (1)

Application Number Title Priority Date Filing Date
TW093108358A TWI367753B (en) 2003-03-27 2004-03-26 Composition for normalization of infradian rhythm

Country Status (9)

Country Link
US (1) US9782377B2 (zh)
EP (1) EP1605930B1 (zh)
JP (1) JP4633048B2 (zh)
KR (1) KR101205516B1 (zh)
CN (2) CN101843610A (zh)
AU (1) AU2004224513B2 (zh)
CA (1) CA2514524C (zh)
TW (1) TWI367753B (zh)
WO (1) WO2004084882A1 (zh)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003048831A (ja) 2001-08-02 2003-02-21 Suntory Ltd 脳機能の低下に起因する症状あるいは疾患の予防又は改善作用を有する組成物
JP4993852B2 (ja) 2004-09-17 2012-08-08 サントリーホールディングス株式会社 ストレスに起因する行動異常を伴う症状あるいは疾患の予防又は改善作用を有する組成物
JP5967855B2 (ja) * 2005-06-30 2016-08-10 サントリーホールディングス株式会社 日中活動量の低下および／又はうつ症状の改善作用を有する組成物
ITMI20060956A1 (it) * 2006-05-16 2007-11-17 Massimo Ronchetti Uso di composizioni a base di colina per il trattamento del tinnito
KR101578498B1 (ko) * 2006-12-28 2015-12-18 산토리 홀딩스 가부시키가이샤 신경 재생제
JP5414192B2 (ja) * 2007-03-29 2014-02-12 江崎グリコ株式会社 概日リズム調整組成物
US8343753B2 (en) 2007-11-01 2013-01-01 Wake Forest University School Of Medicine Compositions, methods, and kits for polyunsaturated fatty acids from microalgae
WO2009058799A1 (en) * 2007-11-01 2009-05-07 Wake Forest University School Of Medicine Compositions and methods for prevention and treatment of mammalian diseases
US8178147B2 (en) * 2008-06-26 2012-05-15 Pepsico, Inc. Coumalic acid to inhibit non-enzymatic browning in teas
CA2754952C (en) * 2009-03-19 2018-11-06 Martek Biosciences Corporation Thraustochytrids, fatty acid compositions, and methods of making and uses thereof
JP5576699B2 (ja) * 2010-04-15 2014-08-20 花王株式会社 Ｇｉｐ上昇抑制剤
JP5951448B2 (ja) 2012-05-15 2016-07-13 国立研究開発法人産業技術総合研究所 概日リズム調整剤
CN103667068A (zh) * 2012-09-14 2014-03-26 罗盖特兄弟公司 一种由微生物（单细胞真菌高山被孢霉）产生的富含花生四烯酸的油及其制备工艺
JP2017214342A (ja) * 2016-06-02 2017-12-07 日清オイリオグループ株式会社 排尿障害の予防用又は改善用組成物
JP6650852B2 (ja) * 2016-09-14 2020-02-19 マルハニチロ株式会社 ドコサヘキサエン酸を含有する睡眠の質改善剤
WO2020014884A1 (zh) * 2018-07-18 2020-01-23 苏州大学 一种筛选去同步化指标的方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5242941A (en) * 1990-12-04 1993-09-07 State Of Oregon Methods of treating circadian rhythm disorders
US5658767A (en) 1991-01-24 1997-08-19 Martek Corporation Arachidonic acid and methods for the production and use thereof
PH11992043811B1 (en) 1991-01-24 2002-08-22 Martek Corp Arachidonic acid and methods for the production and use thereof
GB9617847D0 (en) * 1996-08-27 1996-10-09 Scotia Holdings Plc Fatty acid treatment
FR2762993B1 (fr) * 1997-05-06 1999-08-13 Inst Rech Biolog Sa Nouvelle utilisation de phospholipides d'origine animale en therapeutique et/ou dietetique
ES2312430T3 (es) * 2000-05-16 2009-03-01 Suntory Limited Composicion normalizadora del ritmo circadiano.
JP2003048831A (ja) * 2001-08-02 2003-02-21 Suntory Ltd 脳機能の低下に起因する症状あるいは疾患の予防又は改善作用を有する組成物
CN100418519C (zh) 2002-09-24 2008-09-17 三得利株式会社 用于增强认知能力的含有花生四烯酸或其与二十二碳六烯酸的组合的组合物

Also Published As

Publication number Publication date
KR20050111611A (ko) 2005-11-25
KR101205516B1 (ko) 2012-11-28
CN1756544B (zh) 2011-07-27
US20060073187A1 (en) 2006-04-06
AU2004224513B2 (en) 2010-07-01
AU2004224513A1 (en) 2004-10-07
TW200507832A (en) 2005-03-01
JP2006521369A (ja) 2006-09-21
WO2004084882A1 (en) 2004-10-07
CN101843610A (zh) 2010-09-29
EP1605930A1 (en) 2005-12-21
CN1756544A (zh) 2006-04-05
CA2514524A1 (en) 2004-10-07
EP1605930B1 (en) 2020-06-03
US9782377B2 (en) 2017-10-10
JP4633048B2 (ja) 2011-02-16
CA2514524C (en) 2012-07-10

Similar Documents

Publication Publication Date Title
AU154703S (en) Set of trocars
ZA200605348B (en) Solid forms of anti-EGFR-antibodies
EP1613308A4 (en) CANCER TREATMENT METHODS
EP1603543A4 (en) THERAPEUTIC COMPOSITIONS
EP1745573A4 (en) PROCESS FOR PREPARING 2-DEOXY-BETA-L-NUCLEOSIDES
TWI367753B (en) Composition for normalization of infradian rhythm
GB0329874D0 (en) Compounds useful for the treatment of diseases
EP1608385A4 (en) THERAPEUTIC COMPOSITIONS
GB0305150D0 (en) Use of therapeutic compounds
ZA200407609B (en) Use of vitamin d compounds
GB0323258D0 (en) Therapeutic compounds
IL165839A0 (en) Compounds useful for the treatment of cancer compositions thereof and methods therewith
GB2392618B (en) Compositions for therapeutic use
GB0222945D0 (en) Therapeutic compositions
AU2003282722A8 (en) Therapeutic compositions
GB0304555D0 (en) Compounds and methods of manufacture
GB2398740B (en) Skin composition
GB0327742D0 (en) Novel uses of known drugs
GB0313630D0 (en) Compositions for the enhanced treatment of depression
AU2003240174A8 (en) Compositions for the treatment of edematous-firbrosclerotic panniculopathy
PL377902A1 (pl) Nowe zastosowanie kompleksu fosfor-azot-metal
AU2003205355A1 (en) Methods of administering gaultherin-containing compositions
GB0317128D0 (en) Use of antitumoral compounds
TW560584U (en) Improvement of screw
GB0217750D0 (en) New use of diaza-anthracene compounds

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees